NCT06696586

Brief Summary

Injury and deformity of the upper extremity can result in dysfunction to nerves, tendons and bones which can lead to disability and pain. Various techniques of regional anesthesia are frequently used for upper extremity surgery. Specifically, intravenous regional anesthesia, the Bier block, is an effective anesthetic technique. This technique, developed by Dr August Bier in 1908, provides complete anesthesia, a bloodless field, and eliminates the need for general anesthesia. However, it was not until the 1960s that this technique was reintroduced and used in upper extremity surgery due to several disadvantages and reports of major complications. Because of the dose of lidocaine and tourniquet time, there is potential for cardiac and neurological complications such as arrhythmias, seizures, and compartment syndrome the aim of this study To evaluate the effect of Systemic Fentanyl Infusion compared to addition of Fentanyl as An Adjuvant to Lidocaine in Bier Block for Controlling Pain in Patients Undergoing Hand Surgeries

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for phase_4

Timeline
8mo left

Started Jul 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress57%
Jul 2025Jan 2027

First Submitted

Initial submission to the registry

November 18, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 20, 2024

Completed
7 months until next milestone

Study Start

First participant enrolled

July 1, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

April 18, 2025

Status Verified

April 1, 2025

Enrollment Period

1.4 years

First QC Date

November 18, 2024

Last Update Submit

April 17, 2025

Conditions

Keywords

Systemic Fentanyl InfusionFentanyl Added as An Adjuvant to Lidocaine

Outcome Measures

Primary Outcomes (1)

  • to compare intraoperative pain between systemic and local fentanyl using VAS score

    pain will be assessed using an 11-point (0=no pain and 10=worst pain) VAS scale

    baseline

Study Arms (2)

group 1

EXPERIMENTAL

patients will received lidocaine with dose 250 mg and fentanyl infusion in dose of 200 µg in rate 10ml /hr using 50ml syringe pump

Drug: Fentanyl infusion

group 2

EXPERIMENTAL

patients will receive lidocaine 250 mg in addition to fentanyl injection in dose 100 µg by shots

Drug: Fentanyl Injection

Interventions

will received lidocaine with dose 250 mg and fentanyl infusion in dose of 200 µg in rate 10ml /hr using 50ml syringe pump.

group 1

will receive lidocaine 250 mg in addition to fentanyl injection in dose 100 µg by shots

group 2

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients age from 18 years to 40 years
  • Both sex
  • Patients of the American Society of Anesthesiologists (ASA) physical Status class I and II
  • BMI less than 40

You may not qualify if:

  • Patients who refuse to participate in study.
  • Uncooperative patients.
  • Patient with crush injury
  • Peripheral vascular, neurological or muscle diseases.
  • Coagulation disorders that affect the blood's clotting activities e.g.: Hemophilia.
  • History of hypersensitivity to the drugs being evaluated

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (4)

  • Jung H, Lee KH, Jeong Y, Lee KH, Yoon S, Kim WH, Lee HJ. Effect of Fentanyl-Based Intravenous Patient-Controlled Analgesia with and without Basal Infusion on Postoperative Opioid Consumption and Opioid-Related Side Effects: A Retrospective Cohort Study. J Pain Res. 2020 Nov 24;13:3095-3106. doi: 10.2147/JPR.S281041. eCollection 2020.

    PMID: 33262644BACKGROUND
  • Glick JL, Christensen T, Park JN, McKenzie M, Green TC, Sherman SG. Stakeholder perspectives on implementing fentanyl drug checking: Results from a multi-site study. Drug Alcohol Depend. 2019 Jan 1;194:527-532. doi: 10.1016/j.drugalcdep.2018.10.017. Epub 2018 Nov 13.

    PMID: 30551090BACKGROUND
  • Farzam R, Deilami M, Jalili S, Kamali K. Comparison of Anesthesia Results between Wide Awake Local Anesthesia no Tourniquet (WALANT) and Forearm Tourniquet Bier Block in Hand Surgeries: A Randomized Clinical Trial. Arch Bone Jt Surg. 2021 Jan;9(1):116-121. doi: 10.22038/abjs.2020.49526.2487.

    PMID: 33778124BACKGROUND
  • Badeaux J, Bonanno L, Au H. Effectiveness of ondansetron as an adjunct to lidocaine intravenous regional anesthesia on tourniquet pain and postoperative pain in patients undergoing elective hand surgery: a systematic review protocol. JBI Database System Rev Implement Rep. 2015 Jan;13(1):27-38. doi: 10.11124/jbisrir-2015-1768.

    PMID: 26447005BACKGROUND

MeSH Terms

Interventions

Fentanyl

Intervention Hierarchy (Ancestors)

PiperidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Central Study Contacts

Abdelrahman Mostafa Ibrahim Hashim, resident doctor

CONTACT

Ahmed Mohamed Elsonbaty, lecturer

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The patients will be randomly allocated to one of two groups; each group consisted of 42 patients. Randomization will be performed using a closed envelope method
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident doctor at Anaesthesia and ICU department

Study Record Dates

First Submitted

November 18, 2024

First Posted

November 20, 2024

Study Start

July 1, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

January 1, 2027

Last Updated

April 18, 2025

Record last verified: 2025-04